AGRX - Agile Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts5555
Avg. Estimate-0.17-0.16-0.67-0.76
Low Estimate-0.19-0.18-0.7-1.17
High Estimate-0.16-0.14-0.65-0.27
Year Ago EPS-0.26-0.22-0.91-0.67
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts5555
Avg. EstimateN/AN/AN/A11.81M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A29.74M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.28-0.24-0.24-0.2
EPS Actual-0.26-0.22-0.18-0.2
Difference0.020.020.060
Surprise %7.10%8.30%25.00%0.00%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.17-0.16-0.67-0.76
7 Days Ago-0.17-0.16-0.67-0.76
30 Days Ago-0.17-0.16-0.67-0.76
60 Days Ago-0.19-0.16-0.68-0.81
90 Days Ago-0.22-0.16-0.78-0.82
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/A11
Up Last 30 Days1N/A32
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAGRXIndustrySectorS&P 500
Current Qtr.34.60%N/AN/A0.42
Next Qtr.27.30%N/AN/A0.45
Current Year26.40%N/AN/A0.21
Next Year-13.40%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A